Who Are Brie and Bryan
Brie and Bryan are known primarily through their association with high-profile business and media ventures. Public records and company filings link the name Bryan to Bryan Johnson, the founder and CEO of Braintree, a payments company acquired by PayPal, and the founder of OS Fund, a venture capital firm focused on science-driven companies Forbes. Brie is less frequently referenced in public filings, and available data does not link Brie to a separate major public company or executive role with verifiable financial disclosures.
In SEC filings and public databases, Bryan Johnson appears as a controlling figure in multiple entities, including Braintree, OS Fund, and Kernel, a neurotechnology company developing brain-computer interfaces SEC EDGAR. Public profiles describe Bryan Johnson as an entrepreneur born in 1977 who sold Braintree to PayPal in 2013 for approximately $800 million, a transaction that generated significant liquidity and enabled subsequent investments in science and technology ventures.
Companies and Financial Overview
Braintree, the payments platform Bryan Johnson founded in 2007, processed billions of dollars in transactions before its acquisition by PayPal in 2013 Forbes. OS Fund, launched in 2014, manages a portfolio of early-stage companies in fields such as synthetic biology, materials science, and artificial intelligence, though exact assets under management are not publicly disclosed in recent filings.
Kernel, another company associated with Bryan Johnson, develops non-invasive brain imaging hardware aimed at advancing neuroscience research and potential clinical applications Kernel. Public financial data on OS Fund and Kernel remains limited, as both operate as private companies without mandatory public disclosure of revenue, valuation, or detailed financial statements.
Public Profile and Recent Developments
Bryan Johnson has publicly discussed longevity and human optimization through projects such as Blueprint, a personal health and longevity protocol that combines medical testing, supplements, and lifestyle tracking Forbes. His public statements and interviews emphasize data-driven approaches to health, though independent peer-reviewed validation of Blueprint outcomes is not widely available in major medical journals.
In the broader business landscape, Bryan Johnson remains a visible figure in venture capital and technology circles, with OS Fund and Kernel frequently cited in coverage of science-focused investing SEC EDGAR. Brie does not appear in current public filings or major business databases as a separate executive or company founder with verifiable financial disclosures, and no recent public data links Brie to a distinct corporate role or financial profile.